Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith?
Am J Respir Crit Care Med
.
2020 Feb 15;201(4):405-406.
doi: 10.1164/rccm.201911-2160ED.
Authors
Andrew Vernon
1
,
William Bishai
2
Affiliations
1
Division of TB EliminationCenters for Disease Control and PreventionAtlanta, Georgiaand.
2
Center for Tuberculosis ResearchJohns Hopkins School of MedicineBaltimore, Maryland.
PMID:
31765598
PMCID:
PMC7049924
DOI:
10.1164/rccm.201911-2160ED
No abstract available
Publication types
Editorial
Comment
MeSH terms
Animals
Isoniazid
Latent Tuberculosis*
Macaca
Mycobacterium tuberculosis*
Rifampin / analogs & derivatives
Substances
Isoniazid
Rifampin
rifapentine